Robotic Versus Video-assisted Lobectomy/Segmentectomy for Lung Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
robotic surgery: minimally invasive surgery using the Davinci robotic system
uniport surgery: VATS minimally invasive surgery under the uniportal status
multiple- port surgery: VATS minimally invasive surgery under the multiple- port status
Study summary
To compare the safety/efficacy of the robotic-assisted lobectomy/segmentectomy (RAL/S) with the video-assisted lobectomy/segmentectomy (VAL/S) for lung resection.
Video-assisted lobectomy/segmentectomy (VAL/S) for lung resection is divided into uniport group and multiple- port group.
Eligibility
Primary outcome measure(s)
- mortality — 30 days after surgery
incidence rate - conversion rate to open surgery — during surgery
incidence rate - postoperative complications — within 7 days after surgery
incidence rate - operation time — within 180 minutes
minutes - duration of hospitalization — within 7 days after surgery
days - days to tube removal — within 7 days after surgery
days - retrieved lymph node — within 1 days after surgery
amount - retrieved lymph node station — within 1 days after surgery
amount - short- term PFS — 3 years
proportion - short- term overall survival — 3 years
proportion
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| The Second Hospital of Shandong University | Jinan | Shandong | Recruiting |
More The Second Hospital of Shandong University trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05270616 on ClinicalTrials.gov ↗ ← All trials in China